DNA STRAND BREAKS PRODUCED BY ETOPOSIDE (VP-16,213) IN SENSITIVE AND RESISTANT HUMAN-BREAST TUMOR-CELLS - IMPLICATIONS FOR THE MECHANISM OF ACTION
- 15 September 1988
- journal article
- research article
- Vol. 48 (18) , 5096-5100
Abstract
Pleotropic resistant human breast cancer cells (MFC-7), selected for resistance to Adriamycin, were used to study the production of DNA strand breaks by etoposide (VP-16) and its relationship to drug cytotoxicity. It was shown that the resistant MCF-7 cell line was cross-resistant to VP-16, and the degree of resistance was found to be 125-200-fold. Alkaline elution studies indicated that the parental cell line was very sensitive to VP-16 which caused extensive DNA strand breakage. In contrast, little DNA strand breakage was detected in the resistant MCF-7 cells, even at very high drug concentrations, indicating a good agreement between strand breaks and cytotoxicity. Further studies indicated that the nuclei isolated from the parental cell line were more resistant to VP-16-induced DNA strand breaks than the intact cells, while the opposite was found in the resistant cell line. In addition, the alkaline elution studies in isolated nuclei showed only a 2-fold reduction of VP-16-induced DNA breaks in nuclei from the resistant cells. In agreement with this result, it was found that nuclear extract from the resistant cells produced 2-3-fold less VP-16-induced DNA breaks than from the sensitive cells in 32P-end-labeled SV40 DNA. VP-16 uptake and efflux studies indicated that there was a 2-3-fold decrease in net cellular accumulation of VP-16 in the resistant cells. Although the reduced uptake of VP-16 and decreased drug sesitivity of topoisomerase II appear to to contribute to the mechanism of action and the development of resistance to VP-16, they do not completely explain the degree of resistance to VP-16 in this multidrug-resistant MCF-7 cell line indicating that other biochemical factors, such as activation of VP-16, are also involved in drug resistance and suggesting that the resistance is multifactorial.This publication has 23 references indexed in Scilit:
- Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26)Biochemical and Biophysical Research Communications, 1986
- Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavageBiochemical Pharmacology, 1985
- SINGLE-STRAND AND DOUBLE-STRAND DNA BREAKAGE AND REPAIR IN HUMAN-LUNG ADENOCARCINOMA CELLS EXPOSED TO ETOPOSIDE AND TENIPOSIDE1985
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984
- ROLE OF TOPOISOMERASE-II IN MEDIATING EPIPODOPHYLLOTOXIN-INDUCED DNA CLEAVAGE1984
- EFFECTS OF THE EPIPODOPHYLLOTOXIN VP-16-213 ON CELL-CYCLE TRAVERSE, DNA-SYNTHESIS, AND DNA STRAND SIZE IN CULTURES OF HUMAN-LEUKEMIC LYMPHOBLASTS1983
- DNA DAMAGE AS A BASIS FOR 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-O-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (ETOPOSIDE) CYTO-TOXICITY1983
- The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nucleiBiochemical and Biophysical Research Communications, 1982
- Characteristics of membrane transport of methotrexate by cultured human breast cancer cellsBiochemical Pharmacology, 1981
- Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cellsBiochemistry, 1976